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Introduction
Stress hyperglycemia in the ICU environment is a highly
regarded study subject since Lueven collaborators publi-
cations in 2001. Current research focused on variability
of blood glucose levels suggests it being an independed
predictor of bad clinical outcome. Despite the impor-
tance of the subject the genesis of the variability of the
glycemia is not fully understood.
Objectives
We aim to associate prolonged vasopressors therapy
with glucose variability after cardiac surgery.
Methods
The study was conducted in a tertiary hospital center and
included patients undergoing cardiac surgery. Randomiza-
tion was applied using demographic and operative criteria.
First postoperative day data was used to calculate the glu-
cose variability adopting three hypothetical markers: dif-
ference between highest and lowest blood glucose level
(GluDiff), SD of mean glucose (GluSD) and a group of
patients having both hyper and hypoglycemia (GluHH).
Prolonged vasopressors therapy (PVT) was defined as a
use of sympatomimetic drugs more than 24 hours post-
operatively. Estimation coefficients (B) of PVT were calcu-
lated using decimiles for GluDiff and GluSD. Appropriate
statistical tests were used to adjust for the factors affecting
glucose concentration.
Results
Study included 779 patients, 521 of them in the rando-
mized group. PVT was diagnosed in 201 (38,6%) and was
linked to mean glycemia (7,67 ± 1,31 vs 6,99 ± 1,17 ± p <
0,001). All three glucose variability markers were asso-
ciated with PVT (p < 0,01). Analyzing the decimiles of
GluDiff (B10th=-2,1 to B90th=1,92) and GluSD (B10th=-
2,82 to B90th=1,8) in ordinal regression revealed growth
of estimates linked to the PVT (p < 0,05). This associa-
tion persisted in multivariate regression analysis adjusted
for aortic clamping time, bypass time, gender, age and
other predictors of glucose variability. Furthermore, rate
of PVT was higher in GluHH group (32 (61,5%) vs
129 (37%) p=0,001) suggesting OR of 2,73 (CI95% 1,49-
4,97 p=0,001). In multivariate regression analysis adjusted
for aforementioned criteria PVT persisted as an indepen-
dent predictor of GluHH (OR = 2,38 CI95% 1,18-4,8
p=0,016).
Conclusions
We report the association between prolonged vasopres-
sors therapy and increased blood glucose level. Further-
more, we establish the link between glucose variability
and use of sympatomimetics. However our study lacks
the exact doses of the drugs used so we note the need
of further research in this field.
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